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Edited by Christian GriesingerAbstract Alzheimer’s disease is characterized by progressive
loss of neurons accompanied by the formation of intraneural neu-
roﬁbrillary tangles and extracellular amyloid plaques. Human
neuronal growth inhibitory factor, classiﬁed as metallothionein-
3 (MT-3), was found to be related to the neurotrophic activity
promoting cortical neuron survival and dendrite outgrowth in
the cell culture studies. We have determined the solution struc-
ture of the a-domain of human MT-3 (residues 32–68) by multi-
nuclear and multidimensional NMR spectroscopy in combination
with the molecular dynamic simulated annealing approach. The
human MT-3 shows two metal–thiolate clusters, one in the N-
terminus (b-domain) and one in the C-terminus (a-domain).
The overall fold of the a-domain is similar to that of mouse
MT-3. However, human MT-3 has a longer loop in the acidic
hexapeptide insertion than that of mouse MT-3. Surprisingly,
the backbone dynamics of the protein revealed that the b-domain
exhibits similar internal motion to the a-domain, although the
N-terminal residues are more ﬂexible. Our results may provide
useful information for understanding the structure–function
relationship of human MT-3.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Metallothionein (MT) is a kind of small proteins (typically
6–7 kDa) with an array of conserved 20 cysteines and contains
polynuclear metal–sulfur coordination sites formed by metal
ions with d10 conﬁguration [1]. In mammalian MTs, the two
major metallothionein isoforms (MT-1 and MT-2), which areAbbreviations: AD, Alzheimer’s disease; GST, glutathione-S transfer-
ase; HMQC, heteronuclear multiple-quantum coherence; HSQC, het-
eronuclear single-quantum coherence; MTs, metallothioneins; MT-3,
metallothionein-3; NFT, neuroﬁbrillar tangles; NOE, nuclear Overha-
user eﬀect; NOESY, nuclear Overhauser enhancement spectroscopy;
RMSD, root mean square deviation; SP, senile plaques; TOCSY, total
correlation spectroscopy
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doi:10.1016/j.febslet.2005.12.099expressed in most organs, play a role in the homeostasis of
the essential trace metal (Zn2+ and Cu+) and in the heavy metal
detoxiﬁcation (e.g. Cd2+ and Hg2+), and even in radical scav-
enging and stress response [2]. In the past decade, two tissue-
speciﬁc isoforms were discovered, MT-3 in the central nervous
system and MT-4 in epithelial cells [3].
Alzheimer’s disease (AD), a senile dementia, comprises dys-
function of neurons in brains, in which neuroﬁbrillar tangles
(NFT) and senile plaques (SP) are the major neuropathological
characteristics [4]. It has been found that AD brain extract
shows enhanced neurotrophic activity promoting cortical neu-
ron survival and dendrite outgrowth in the cell culture studies
[5–8]. The enhanced activity was shown to be due to the down-
regulation of a neuronal growth inhibitory factor, which was
isolated from normal human brains, and was subsequently
shown to belong to the family of metallothioneins (MTs)
and designated as MT-3 [9,10]. Its characterization revealed
a metallo-protein of 68 amino acids containing four copper
and three zinc ions with its primary structure exhibiting
approximately 70% sequence identity with those of mamma-
lian metallothioneins (MT-1/MT-2 isoforms: 61 or 62 amino
acids), including the preserved array of 20 cysteine residues
[11]. In contrast to the amino acid sequences of mammalian
MT-1/MT-2, MT-3 contains two conserved insertions: a single
Thr in the N-terminal region and a glutamate-rich hexapeptide
(EAAEAE) near the C-terminus (Fig. 1). Additionally, all
known primary sequences of mammalian MT-3 contain the
conserved Cys6-Pro-Cys-Pro9 motif, which was shown to be
involved in the growth inhibitory activity [13,14]. Speciﬁcally,
MT-3 has been suggested to participate in the utilization of
zinc as a neuromodulator since it is massively expressed in neu-
rons that sequester zinc in their synaptic vesicles [15].
Three-dimensional structures of MT isoforms have been re-
ported previously, mostly on MT-1 and MT-2 [16–23]. Due to
lack of well-deﬁned secondary structure elements, their overall
fold is dictated mostly by a clustered network of metal–thiolate
bonds among the sulfur atoms of the cysteine residues and the
metal ions, usually represented by zinc, copper, and cadmium
[24]. It was shown that MT-3, similar to the MT-1 and MT-2,
comprises two domains each wrapping around a metal–thio-
late cluster – M4S11 in the C-terminal a-domain and M3S9 in
the N-terminal b-domain by 113Cd NMR spectroscopy
[25,26]. Functional diﬀerences between MT-3 and the other
mammalian MT isoforms may implicate some structural
and/or dynamic diﬀerences. Therefore, it would be of interestblished by Elsevier B.V. All rights reserved.
Fig. 1. Sequence alignment of human MT2A, human MT3, mouse MT3 and rat MT3 was created using the program CLUSTALX [12]. The
conserved cysteines are shown in bold. The residues conserved in all four isoforms are highlighted in gray. The numbering is made according to the
human MT-3 sequence.
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spite of the structure of the a-domain of mouse MT-3 being re-
ported [22]. We have previously examined the uptake and re-
lease of Zn2+ (and Cd2+) ions from the human MT-3 [27]. In
the present study, we have determined the three-dimensional
structure of the a-domain of human Cd7-MT-3 by multinu-
clear and multidimensional NMR spectroscopy together with
molecular dynamic simulated annealing. The backbone
dynamics of both domains were also examined by 15N-relaxa-
tion experiments.2. Materials and methods
2.1. Expression and puriﬁcation of human Cd7-MT-3
The DNA sequence of human Cd7-MT-3 was cloned into a pGEX-
4T-2 (Pharmacia Biotech) vector. As described in our previous paper
[27], the resultant plasmid was transformed into Escherichia coli
BL21 and overexpressed as a glutathione-S transferase (GST)-tagged
fusion protein. The protein was puriﬁed by glutathione–Sepharose
4B aﬃnity column (Amersham Pharmacia Biotech) with some modiﬁ-
cations in the instructions [28], and was cleaved by thrombin at the site
between GST and the target sequences leaving additional Gly-Ser
dipeptide at the N-terminus. The protein was further puriﬁed and de-
salted by size-exclusion chromatography. Isotopically enriched MT-3
was prepared in the M9 minimal medium containing 1 g/L 15N-ammo-
nium chloride (15NH4Cl, Cambridge Isotopes Laboratory). The
113Cd
reconstitution of human MT-3 was carried out using a modiﬁed meth-
od described previously [29]. Brieﬂy, the sample was incubated with ex-
cess 1,4-dithiothreitol (DTT) and lowered its pH to ca. 1–2 to remove
the metals. The sample was then desalted with gel ﬁltration chromatog-
raphy at pH 2.0. Known amount of 113Cd2+ (8 mol equivalents) were
added slowly into the protein solution under argon. The solution
was then titrated with 100 mM Tris base to pH 8.5 and then treated
with chelex-100 to remove excess metals.
2.2. NMR spectroscopy
All the NMR experiments were performed on a Bruker Avance 600
(and a Varian 600 Inova) spectrometer (except for 113Cd NMR), oper-
ating at a proton frequency of 600.13 MHz. Resonances of the Cd-
reconstituted human MT-3 were assigned using spectra acquired with
about 2 mM 15N-labeled hMT-3 in 15 mM sodium phosphate, pH 7.3,
90% H2O/10% D2O with addition of 0.02% (w/v) sodium azide. The
temperature of all the experiments was typically set to 298 K. Solvent
suppression was accomplished using the 3-9-19 WATERGATE pulse
sequence [30]. The backbone and side-chain resonances of MT-3 were
assigned by a combination of 2D 15N-decoupled total correlation spec-
troscopy (TOCSY), 15N-decoupled nuclear Overhauser enhancement
spectroscopy (NOESY), 1H–15N heteronuclear single-quantum coher-
ence (HSQC) and 3D 15N-edited-HSQC-TOCSY, 15N-edited-HSQC-
NOESY. Intramolecular distance restraints were obtained from 2D
15N-decoupled NOESY and 3D 15N-edited-HSQC-NOESY spectra
both using a mixing time of 150 ms. All the NMR data were processed
using nmrPipe and nmrDraw [31], and analyzed by Sparky software
[32].
The 113Cd NMR experiments were performed on a Bruker DRX-500
spectrometer. All the spectra were obtained at 310 K with ca. 1 mM
113Cd-reconstituted hMT-3 in 15 mM phosphate, pH 7.3, 90% H2O/
10% D2O containing 0.02% (w/v) sodium azide. The
113Cd NMR spec-trum was recorded using an inverse gated broad-band proton decou-
pling. A spectral width of 26667 Hz, an acquisition time of 0.31 s
and a pulse repetition rate of 0.5 s were used. The 113Cd resonances
are given in parts per million relative to an external standard
Cd(ClO4)2. Metal-to-ligand (
113Cd and cysteine residues) connectivities
were determined by 2D 1H–113Cd heteronuclear multiple-quantum
coherence (HMQC) NMR experiments. Each transient of 2048 com-
plex points was accumulated with 128 scans for 256 increments in t1
dimension. 3J(1H,113Cd) was varied over the range of 20–70 Hz.
The 1H and 15N chemical shifts of the a-domain have been deposited
in BioMagResBank (BMRB Accession No.: 6909).
2.3. Structure calculations
The structure of the a-domain in human MT-3 was calculated iter-
atively by CYANA (version 2.0) [33]. Inter-proton distance restraints
were derived from the 2D 15N-decoupled NOESY and 3D 15N-edi-
ted-HSQC-NOESY with mixing times of 150 ms using the automated
nuclear Overhauser eﬀect (NOE) assignment strategy followed by a
manual check. NOE intensities and chemical shifts were extracted
using the Sparky3.0 [32], and served as an input for the CYANA.
The CYANA performs automated NOE-assignment, distance calibra-
tion of NOE intensities, removal of covalently ﬁxed distance restraints,
structure calculation with torsion angle dynamics, and automatic NOE
upper distance limit violation analysis [34]. The four Cd2+ ions in the
a-domain were deﬁned in CYANA as new patch residues (CD) con-
taining only the metal ions, and were linked to the end of the polypep-
tide chain of special linker residues (LLM). Information about the
cadmium–sulfur bond lengths and cadmium–CB distances in the me-
tal-ion-to-ligand connectivities, as well as the distances of sulfur–sulfur
of the metal cluster geometry, was taken from the 3D structure of rat
liver [Cd7]-metallothionein-2a [16]. Only upper distance limit of cad-
mium–sulfur cluster was incorporated into structural calculation.
More than 95% of the input NOE data are assigned during the struc-
tural calculation. Two hundred random conformers were annealed in
10000 steps using the distance restraints. The 30 structures with the
lowest target function and 2 NOE violations >0.2 A˚ (0.25 and
0.32 A˚) and no violations >5.0 for angle restraints were energy-mini-
mized under a second generation force ﬁeld [35], using a non-bounded
cut oﬀ of 8.0 A˚ and a generalized Born solvent model [36] in AMBER7
package [37,38]. Structure generation and analysis were performed
with the MOLMOL [39].
2.4. 15N relaxation measurements
15N longitudinal relaxation times (T1),
15N spin–lattice relaxation
times (T2) and
1H–15N NOE measurements were performed, using
the pulse sequences described previously [40]. For T1 measurements,
the spectra were collected with relaxation delays of 10, 50, 100, 200,
300, 450, 600, and 850 ms. For T2 measurements, data were acquired
with delays of 16, 32, 48, 64, 96, 112, 128, 176, 320 ms. A recycle delay
of 3 and 2 s was used for the T1 and T2 relaxation experiments, respec-
tively. A total of 2048 complex data with 200 complex increments were
collected for the relaxation experiments. The T1 and T2 were deter-
mined by ﬁtting the cross-peak intensities to a mono-exponential func-
tion. Error estimates were determined using standard propagation of
errors treatment [40]. The 1H–15N steady-state NOE values were deter-
mined from a pair of spectra, recorded with and without proton satu-
ration. The NOE experiment with proton saturation was carried out
with a 3.5 s interscan relaxation delay followed by 2 s of proton satu-
ration, while the NONOE experiment used a 3.5 s interscan relaxation
delay without proton saturation. NOE values were determined as
the ratio of the peak volume with proton saturation to that without
saturation.
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3.1. Assignment and structure determination
HumanMT-3 was cloned and expressed in E. coli and 113Cd-
hMT-3 was prepared via addition of appropriate amount of
113Cd2+ ions (Section 2). Seven 113Cd NMR signals between
580 and 690 ppm were observed for 113Cd reconstituted MT-
3 with chemical shifts being almost identical to that of previ-
ously reported hMT-3 under similar conditions [7]. This sug-
gests that all of the Cd2+ ions bind to thiolates of cysteines
tetrahedrally, similar to human MT-1/2 and mouse MT-3.
Peaks I, V, VI and VII can be assigned to Cd2+ ions in the
a-domain domain, while the relative broad peaks II, III and
IV are Cd2+ ions in the b-domain (Fig. 2). Metal-to-cysteine
connectivities were veriﬁed by a series of 2D 1H–113Cd HMQC
experiments (Fig. 3), and the connectivities in the a-domain
were summarized in Fig. 4, which were found to be identical
to those of mMT-3.
Structural and dynamic study of human Cd7-MT-3 was car-
ried out at pH 7.3 (15 mM phosphate) at 298 K. Fig. 5 shows a
2D 1H–15N heteronuclear single-quantum coherence (HSQC)VI
VII
I
V
700 660 620 580
113Cd/ppm
Fig. 2. The 500 MHz 113Cd NMR spectrum of 113Cd-reconstituted
human MT-3 in 15 mM phosphate, pH 7.3, 310 K. The labeled
number indicated the assignment of 113Cd resonance in the two
domains. Resonances I, V, VI and VII are in the a-domain, whereas
resonances II, III and IV are in the b-domain.
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Fig. 3. The 500 MHz two-dimensional 1H–113Cd HMQC spectrum of
113Cd-reconstituted human MT3 with 3J(1H,113Cd) of 30 Hz in 15 mM
phosphate, pH 7.3, 310 K. The assignments are indicated by residue
number and one-letter amino acid code. The labeled number in the
113Cd NMR spectra indicated the 113Cd resonances in the two
domains, i.e., resonances I, V, VI and VII in the a-domain whereas
resonances II, III and IV in the b-domain.spectrum of hMT-3, indicating the backbone HN and 15N
cross-peaks of individual residues. Backbone and side-chain
resonance assignments were obtained by standard procedures
based on proton-detected NMR experiments including 2D
15N-decoupled TOCSY, 15N-decoupled NOESY, 1H–15N
HSQC and 3D 15N-edited-HSQC-TOCSY, and 15N-edited-
HSQC-NOESY. All non-proline backbone amide resonances
in the a-domain were assigned except Ser36 and Ser65 which
are missing. Backbone amide resonances of several fragments
(Glu4-Cys6, Gly11-Cys14, Cys16-Ser19, Lys21-Glu23, Lys26-
Cys27 and Cys30-Lys31) in the b-domain were assigned based
on characteristic spin systems and their sequential NOEs. Over
90% side-chain protons in the a-domain were subsequently as-
signed from these NMR spectra. The presence of strong NOEs
for the HNi and H
N
iþ1 pairs and medium range NOEs such as
daN(i,i + 3) and dab(i,i + 3) indicates that the a-domain of human
MT-3 consists of a short a-helices in the region of Lys44-
Lys47.
No long-range interdomain NOEs could be identiﬁed, and
only few medium- and long-range NOEs in the b-domain were
observed. Therefore, structure calculation was preformed only
for the a-domain (residues 32–68) in the present study. A total
389 NOESY cross-peaks were interactively picked giving a to-
tal of 287 non-redundant upper limit distance constraints with
202 short-range, 49 medium-range and 36 long-range (Table
1). The best 30 CYANA structures give an average target func-
tion of 0.32, two NOE violation larger than 0.2 A˚ (0.25 and
0.32 A˚, respectively) and no angle constrain violation larger
than 5. The root mean square deviation (RMSD) of residues
Lys32-Gln68 relative to the mean structure was 1.64 (±0.46) A˚
for the backbone and 2.29 (±0.48) A˚ for the heavy atoms. The
two segments (residues Cys34-Cys51 and Glu62-Gln68) are
much better deﬁned than the whole domain, with RMSD val-
ues 0.87 (±0.31) A˚ for the backbone atoms and 1.79 (±0.34) A˚
for the heavy atoms. The acidic loop is not very well deﬁned
relatively to these two segments due to few NOEs present.
These structures were further energy minimized with the pro-
gram of AMBER7 [37,38] under the force ﬁeld [35] using a
generalized Born solvent model [36]. The statistics for the ﬁnal
30 structures are shown in Table 1.
3.2. Structure of a-domain in human MT-3
The NMR solution structures of the a-domain in human
Cd7-MT-3 (residues Lys32-Gln68) are shown in Fig. 6. The
ensembles were obtained by superimposing the backbone coor-
dinates of the 10 lowest energy structures from two segments
(residues Cys34-Cys51 and Glu62-Gln68). The ribbon diagram
of the mean structure with the bound metal ions (Cd2+) is also
shown in Fig. 6. All the 11 cysteine residues in the a-domain
coordinated to four cadmium ions to form a stable metal–
thiolate cluster, which constrains the overall structure of the
a-domain. Four b-turn fragments can be identiﬁed, i.e.,
Ser36-Ala38, Pro39-Glu41, Val50-Lys52 and Cys64-Cys66.
Similar to mouse MT-3, the backbone conformation of human
MT-3 shows a striking similarity to mammalian MT-1 and
MT-2 [16–18,20] (Fig. 7). In contrast to mouse MT-3, the solu-
tion structure of human MT-3 shows a slightly longer loop
from Lys52 to Ala61 in the acidic hexapeptide insertion than
that of mouse MT-3 (from Lys 52 to Glu60) [22]. Moreover,
the acidic EAAEAE insertion in the a-domain is unrestricted
by the metal–thiolate cluster. We have shown previously that
the EAAEAE insertion aﬀected the property of human MT-3
Fig. 4. The metal-to-ligand (Cd2+ and cysteines) connectivities in the a-domain of human Cd7-MT-3. The metal ions are speciﬁed by roman
numerals given in the sequence according to the assignment of 113Cd resonance in Fig. 2. The coordinative bonds are indicated by straight lines as
determined by 2D 1H–113Cd HMQC experiments. The cysteine residues are highlighted in red, and the positions of the Cys ligands are given with
arabic numerals.
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Fig. 5. The 600 MHz two-dimensional 1H–15N HSQC spectrum of
15N-labeled human Cd7-MT-3 in 15 mM phosphate, pH 7.3, 298 K.
The assignments are indicated by residue number and one-letter amino
acid code.
Table 1
Statistics of the ﬁnal 30 structures of the a-domain of human Cd7-
MT-3
Total number of NOE cross-peaks 389
Non-redundant distance constraints
Total 287
Short range (|i  j| = 1) 202
Medium range (1 < |i  j| < 5) 49
Long range (|i  j| P 5) 36
Residual NOE target function (A˚2) 0.32 ± 0.07
Residual NOE distance limit violations
P 0.2 A˚ 2
Maximum (A˚) 0.32
Average violation 0.08 ± 0.07
AMBER energy (kcal/mol2) 3171.61 ± 19.57
RMSD from the mean coordinates (A˚)
Residues 32–68
Backbone atoms 1.64 ± 0.46
All heavy atoms 2.29 ± 0.48
Residues 34–51, 62–68
Backbone atoms 0.87 ± 0.31
All heavy atoms 1.76 ± 0.34
Fig. 6. Solution structure of the a-domain of human MT-3. NMR
solution structure ensembles (residues Cys34-Cys51 and Glu62-Gln68)
generated by superimposing the backbone coordinates of the 10 best-
converged structures (Upper). Ribbon diagram of the mean structure
of a-domain of human MT-3 showing a short a-helices (Lower). Cd2+
ions are highlighted in purple balls, and their corresponding 113Cd
resonances are labeled in Fig. 2. The atomic coordinates have been
deposited in the Protein Data Bank (PDBID: 2F5H).
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bility of the metal–thiolate cluster [27]. Similar to mouse MT-
3, the stretch of a-helices between residues Lys44-Lys47 is alsoidentiﬁable, but a short helix in the C-terminus could not be
obtained.3.3. Dynamics of human MT3
The backbone dynamics of uniformly 15N-labeled human
Cd7-MT-3 have been studied by using
15N relaxation data ob-
tained from proton-detected 2D 1H–15N HSQC spectroscopy
at 298 K. 15N longitudinal (T1) and transverse (T2) relaxation
time constants and steady-state heteronuclear 1H–15N NOEs
were determined for 30 residues (excluding a proline residue
and two missing serine residues) in the a-domain and 18 as-
signed residues in the b-domain, and the data are shown in
Fig. 8.
In the a-domain, 15N T1 values were fairly constant through-
out the sequence with the mean values of 384 ± 55 ms except
Residue
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Fig. 8. The 15N backbone amide relaxation parameters in the a-
domain and the assigned residues in the b-domain of human Cd7-MT-
3. The values of T1, T2 and proton-irradiated NOE for individual
residues are shown as a function of residue number in the protein
sequence.
Fig. 7. Superposition of the minimized average structures of a-domain
backbones of humanMT-3 (magenta) andmouseMT-3 (cyan) in ribbon
diagram. Cd2+ ions are highlighted in spheres, and labeled according to
their corresponding 113Cd resonances in Fig. 2.
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ysis gives an average value of 167 ± 34 ms and large variations
in T2 were observed over the sequence. As shown in Fig. 8, in-
creased T2 values were observed for residues Asp48, Lys52-
Lys63, and Gln68. These residues also displayed lower NOEs
(<0.6). The increased T2 and lower NOE values reﬂected therelative rapid internal dynamics in the acidic loop and indi-
cated the disorder of the structure in this insertion, in consis-
tent with our calculated structures (Fig. 6).
In the b-domain, completed sequential assignment was not
possible owing to limited cross-peaks observed in the NMR
spectra, the backbone amide resonances were only partially
identiﬁed. The 15N relaxation analysis was only performed on
the 18 assigned residues, which could give rise to some informa-
tion about the internal dynamics in this domain. Relatively
longer T2 values and lower NOE values for the residues
Glu4-Cys6, Gly11 and Gly12 were observed compared to the
a-domain (except to the loop region), indicating more rapid
internal motion in this region of the b-domain of hMT-3. Inter-
estingly, similar T2 values and NOE values were observed be-
tween the rest of other assigned residues in the b-domain
(Ser13-Lys31) and those in the a-domain except the dynamic
loop. These data indicated that the region of Ser13-Lys31 in
the b-domain had a similar dynamic feature (sm  4.3 ns) to
that in the a-domain excluding the loop region, probably attrib-
uting to the cysteine-rich region which forms a metal cluster
and thus restricts the motion of the backbone in this region.
While the rapid internal motion of the N-termini in the b-do-
main is likely due to the Cys6-Pro-Cys-Pro9 tetrapeptide and
diﬀerent conformations of prolines may lead to the b-domain
exhibiting more conformational ﬂexibility in this region. Dy-
namic studies on the b-domain of mouse MT-3 was performed
previously, however with no reported assignment [22], and the
backbone dynamics were examined based on average values of
T1, T2 and NOEs for the residues apart from those belong to
the a-domain. In the present study, we have for the ﬁrst time,
assigned 18 residues in the b-domain and demonstrated that
the b-domain could has a similar dynamic behavior to the a-do-
main, only the N-terminal residues (ca. 12 residues) are more
ﬂexible. These results may provide useful information for the
structure and function of MT-3 and may lead to resolving the
structure of the b-domain of MT-3 in future.
In summary, the structure of the a-domain of hMT-3 was
determined by NMR spectroscopy. Although the overall struc-
ture is similar to that of mouse MT-3, slightly longer loop in
the region of Lys52-Ala61 than the mouse MT-3 was observed.
Surprisingly, the backbone dynamics of the protein were sim-
ilar in both domains except several residues in the N-terminus
(b-domain) and the loop in the a-domain. It would be of inter-
est for further work to examine how does this structure aﬀect
the metal uptake and release.
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